Scheld WM, Brodeur JP: Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis. Antimicrob Agents Chemother23:108-112,1983
Moxon ER, Vaughn KA: The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: Studies using clinical isolates and laboratory transformants. J Infect Dis143:517-524, 1981
10.
Roberts M., Stull TL, Smith AL: Comparative virulence of Haemophilus influenzae with a type B or type D capsule . Infect Immun32:518-524,1981
11.
Cross AS, Gemski P., Sadoff JC, et al: The importance of the K1 capsule in invasive infections caused by Escherichia coli. J Infect Dis149:184-193, 1984
12.
McGee ZA, Baringer JR: Acute meningitis, in Mandell GL, Douglas RG Jr, Bennett JE (eds): Principles and Practice of Infectious Diseases (ed 3). New York, NY, Churchill Livingstone, 1990, pp 741-754
13.
Quagliarello VJ, Long WJ, Scheld WM: Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. J Clin Invest77:1084-1095,1986
14.
Saez-Llorens X., Ramilo O., Mustafa MM, et al: Molecular pathophysiology of bacterial meningitis: Current concepts and therapeutic implications. J Pediatr116:671-684,1990
15.
Blackwell CC , Jansdottir K., Weir DM, et al: Blood group, secretor status, and susceptibility to bacterial meningitis. FEMS Microbiol Lett47:351-356, 1989
16.
Greenwood BM : Selective primary healthcare: Strategies for control of disease in the developing world. XII. Acute bacterial meningitis . Rev Infect Dis6:374-389, 1984
17.
Baumgartner ET, Augustine A., Steele RW: Bacterial meningitis in older neonates. Am J Dis Child137:1052-1054, 1983
18.
Glade MP, Sutton A., Robins JB, et al: Neonatal bacterial meningitis and enteric diseases of infants and children. J Infect Dis136:S93-S97, 1977 (suppl)
Swartz MN, Dodge PR: Bacterial meningitis: A review of selected aspects. N Engl J Med272:725-731, 1965 (suppl)
21.
Schlech WF III, Ward JI, Band SD, et al: Bacterial meningitis in the United States, 1978 through 1981: The national bacterial meningitis surveillance study. JAMA253:1749-1754,1985
22.
Vedros NA: Development of meningococcal serogroups, in Vedros NA (ed): Evolution of Meningococcal Disease, vol 2. Boca Raton, FL, CRC, 1987, pp 33-38
23.
Gorse GJ, Thrupp LD, Nudleman KL: Bacterial meningitis in the elderly. Arch Intern Med144:1603-1607, 1984
24.
Rahal JJ, Simberkoff MS: Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis . Ann Intern Med96:468-474, 1982
25.
Rahal JJ, Simberkoff MS, Landesman SH, et al: Prospective evaluation of moxalactam therapy for gram-negative bacillary meningitis. J Infect Dis149:562-567, 1984
26.
Berk SL, McCabe WR: Meningitis caused by gram-negative bacilli. Ann Intern Med93:253-260,1980
27.
Crane LR, Lerner AM: Nontraumatic gram-negative bacillary meningitis in the Detroit Medical Center 1964-1974. Medicine57:197-209, 1978
28.
Cherubin CE , Marr JS, Sierra MF, et al: Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults . Am J Med71:199-209, 1981
29.
Lorber J., Segall M.: Bacterial meningitis in Spina Bifida Cystica: Review of 37 cases. Arch Dis Child37:300-308, 1962
30.
Mendez-Cashion D., Cordero R.: Recurrent meningitis associated with congenital dermal sinus. Ann Intern Med54:503-509, 1961
31.
Quaade F., Kristensen KP: Purulent meningitis. Acta Med Scand171:543-550, 1962
32.
Roberts FJ, Smith JA, Wagner KR: Staphylococctrs aureus meningitis: 26 years' experience at Vancouver General Hospital. Can Med Assoc J128:1418-1420, 1983
33.
Sahs AL, Joynt RJ: Clinical Neurology.(revised ed). New York, NY, Harper & Row, 1986
34.
Schlesinger LS, Ross SC, Schaberg DR: Staphylococcus aureus meningitis: A broad-based epidemiologic study. Medicine66:148-156, 1987
35.
Wellman WE, Senft RA: Bacterial meningitis III: Infections caused by Staphylococcus aureus. Mayo Clin Proc39:263-269, 1964
36.
Forward KR, Fever HD, Stiver HG: Cerebrospinal fluid shunt infections: A review of 35 infections in 32 patients . J Neurosurg59:389-394, 1983
37.
Schoenbaum SC, Gardner P., Shillito J.: Infections of cerebrospinal fluid shunts: Epidemiology, clinical manifestations, and therapy. J Infect Dis131:543-552, 1975
38.
Heerema MS, Ein ME, Musher DM, et al: Anaerobic bacterial meningitis. Am J Med67:219-227, 1979
Hogan GW: Manual of clinical problems in neurology. Boston, MA,Little, Brown, 1984
41.
Geiseler PJ , Nelson KE, Levin S., et al: Community-acquired purulent meningitis: A review of 1,316 cases during the antibiotic era, 1954-1976. Rev Infect Dis2:725-745, 1980
42.
Gordon JJ, Harter DH, Phair JP: Meningitis due to Staphylococcus aureus. Am J Med78:965-970, 1985
43.
Overturf GD, Hoeprich PD: Bacterial meningitis, in Hoeprich PD (ed): Infectious Diseases (ed 3). New York, NY, Harper & Row, 1983, pp 1035-1061
44.
Dodge PR, Swartz MN: Bacterial meningitis: A review of selected aspects II: Special neurologic problems, post meningitic complications and clinical pathological correlations . N Engl J Med272:954-960,1965
45.
Beach RC, Clayden GS, Eykyn SJ: Waterhouse-Friderichsen Syndrome caused by Haemophilus influenzae type b. Br Med J2:1111,1979
46.
Jacobs RF, Hsi S., Wilson CB: Apparent meningococcemia: Clinical features of disease due to Haemophilus influenzae and Neisseria meningitidis. Pediatrics72:469-472, 1983
47.
Sjursen H., Hofstad T., Fuglesang P., et al: Waterhouse-Friderichsen Syndrome caused by Haemophilus influenzae type b in an adult. Infection9:300-301, 1981
48.
MacDonald NE , Keene DL, MacKenzie Amr, et al: Fulminating Haemophilus influenzae meningitis. Can J Neurol Sci11:78-81, 1984
49.
Robinson RO , Robert H.: Acute bacterial meningitis I: Diagnosis. Developmental medicine and child neurology32:79-86, 1990
50.
Klein JO, Geigin RD, McCracken GH: Report of the task force on diagnosis and management of meningitis. Pediatrics75:959-982, 1986 (suppl 5)
51.
Conly JM, Ronald AR: Cerebrospinal fluid as a diagnostic body fluid. Am J Med75:102-108, 1983
52.
Bohr V., Rasmussen N., Hansen B., et al: 875 cases of bacterial meningitis: Diagnostic procedures and the impact of pre-admission antibiotic therapy. J Infect7:193-202, 1983
53.
Karandanis D., Shulman JA: Recent survey of infectious meningitis in adults: Review of laboratory findings in bacteria], tuberculous, and aseptic meningitis. South Med J69:449-457, 1976
54.
Marton KI, Gean AD: The spinal tap: A new look at an old test. Ann Intern Med104:840-848, 1986
55.
Lepper MH, Dowling HF: Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin: Studies including observations on an apparent antagonism between penicillin and aureomycin. Arch Intern Med88:489-494,1951
56.
Mathies AW, Leedom JM, Ivler D., et al: Antibiotic antagonism in bacterial meningitis. Antimicrob Agents Chemother7:218-224, 1967
57.
Rahal JJ, Hyams PJ, Simberkoff MS, et al: Combined intrathecal and intramuscular gentamicin for gram-negative meningitis: Pharmacologic study of 21 patients. N Engl J Med290:1394-1398, 1974
58.
Winslow DL, Damme J., Dieckman E.: Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: Antagonism of chloramphenicol and rifampin. Antimicrob Agents Chemother23:555-558, 1983
59.
Feder HM, Osier C., Maderazo EG: Chloramphenicol: A review of its use in clinical practice. Rev Infect Dis3:479-491,1981
60.
Rahall JJ, Simberkoff MS: Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens. Antimicrob Agents Chemother16:13-18, 1979
61.
Schaad UB, McCracken GH Jr, Loock CA, et al: Pharmacokinetics and bacteriological efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis . J Infect Dis143:156-163,1981
62.
Scheld WM, Brown RS Jr, Sande MA: Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother13:899-904,1978
63.
Schetd WM, Sande MA: Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest71:411-419, 1983
64.
Tunkel AR, Wispelwey B., Scheld M.: Bacterial meningitis: Recent advances in pathophysiology and treatment. Ann Intern Med112:610-623,1990
65.
Rotschafer JC, Vance-Bryan K., Zabinski RA: Antibiotic pharmacodynamics in the critically ill patient. Florida J Hosp Pharm10:1991 (in press)
66.
Levison ME, Bush LM: Pharmacodynamics of antimicrobial agents: Bactericidal and postantibiotic effects. Infect Dis Clin North Am3:415-420, 1989
McCracken GH , Mize SG: A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. J Pediatr89:66-72, 1976
69.
Givner LB, Abramson JS, Wasilauskas B.: Meningitis due to Haemophilrts influenzae type b resistant to ampicillin and chloramphenicol. Rev Infect Dis11:329-334, 1989
70.
Campos J., Garcia-Tornel S., Sanfeliu I.: Susceptibility studies of multiple resistant Haemophilus influenzae isolated from pediatric patients and contacts. Antimicrob Agents Chemother25:706-709,1984
71.
Campos J., Garcia-Tornel S., Gairi JM, et al: Multiply resistant Haernophilus influenzae type b causing meningitis: Comparative clinical and laboratory study. J Pediatr108:897-902,1986
72.
Marks WA, Stutman HR, Marks MI, et al: Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: A multicenter randomized controlled trial. J Pediatr109:123-130, 1986
73.
Peter G.: Treatment and prevention of Haemophilus influenzae type b meningitis. Pediatr Infect Dis J6:787-790, 1987
74.
The choice of antimicrobial drugs. Med Lett Drugs Ther32:41-48, 1990
75.
DiNubile MJ : Meningitis due to pneumococcus (let. ter). Rev Infect Dis12:717-718, 1990
76.
Weingarten RD, Markiewicz Z., Gilbert DN: Meningitis due to penicillin-resistant streptococcus pneumoniae in adults. Rev Infect Dis12:118-124, 1990
77.
Caputo GM, Sattler FR, Jacobs MR, et al: Penicillin-resistant pneumococcus and meningitis. Ann Intern Med98:416-417, 1983 (letter)
78.
Riefler JF III, Miller HA, DiNubile MJ: Meningitis and endocarditis due to infection by penicillin-resistant pneumococcus . Infect Med5:551-556,1988
79.
Viladrich PF , Gudiol F., Linares J., et al: Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med84:839-846, 1988
80.
Dillon JR, Pauze M., Yeung HK: Spread of penicillinase-producing and transfer plasmids from the gonococcus to Neisseria meningilidis. Lancet1:779-781, 1983
81.
Campos J., Mendelman PM, Sako MU, et al: Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob Agents Chemother31:1478-1482, 1987
82.
Van Esso D. , Fortanals D., Uriz S., et al: Neisseria meningitidis strains with decreased susceptibility to penicillin. Pediatr Infect Dis6:438-439, 1987
83.
Rodriguez WJ , Khan WN, Cocchetto DM, et al: Treatment of Pseudomonas meningitis with ceftazidime with or without concurrent therapy. Pediatr Infect Dis J9:83-87, 1990
84.
Fong IW, Tomkins KB: Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime. Rev Infect Dis7:604-612, 1985
85.
Norrby SR: 4-quinolones in the treatment of infections of the CNS. Rev Infect Dis10:S253-S257, 1988 (suppl 1)
86.
Montay G., Gouffon Y., Roquet F.: Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans. Antimicrob Agents Chemother25:463-472, 1984
87.
Nagatsu Y., Endo K., Irikura T.: Studies on the fate of 14-C-labeled AM-715. Chemotherapy (Tokyo) 29:98-118, 1981 (suppl 4).
88.
Wolff M., Regnier B., Daldoss C., et al: Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis. Antimicrob Agents Chemother26:89-91, 1984
89.
Buckley R.: Safety and efficacy of chronic oral ciprofloxacin suppressive therapy in a patient with chronic relapsing Pseudomonas meningitis. Abstracts of the International Symposium on New Quinolones256,1986 (abstr)
90.
Isaacs D., Slack Mpe, Wilkinson AR, et al: Successful treatment of Pseudomonal ventriculitis with ciprofloxacin . J Antimicrob Chemother17:535-538, 1986
Trautman M. , Wagner J., Chahin M., et al: Listeria meningitis: Report of ten recent cases and review of current therapeutic recommendations. J Infect10:107-114, 1985
Cherubin CE , Marr JS, Sierra MF, et al: Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults . Am J Med71:199-209,1981
95.
Schlesinger LS, Ross SC, Schaberg DR: Staphylococcus aureus meningitis: A broad-based epidemiologic study. Medicine66:148-156, 1987
96.
Brumfitt W. , Hamilton-Miller J.: Methicillin-resistant Staphylococcus aureus . N Engl J Med320:1188-1196, 1989
97.
Radetsky M. : Duration of treatment in bacterial meningitis: A historical inquiry. Pediatr Infect Dis J9:2-9, 1990
98.
Somers Rbu: M-B693 in cerebrospinal fever: A review of 143 cases treated under field conditions . Lancet1:921-922,1939
99.
Lin T-Y., Chrane DF, Nelson JD, et al: Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis. JAMA253:3559-3563, 1985
100.
Schaad UB, Nelson JD, McCracken GH: Recrudescence and relapse in bacterial meningitis of childhood. Pediatrics67:188-195,1981
101.
Niemoller UM, Tauber MG: Brain edema and increased intracranial pressure in the pathophysiology of bacterial meningitis. Eur J Clin Microbiol Infect Dis8:109-117,1989
102.
Lebel MH, Bishara JF, Syrogiannopoulos GA, et al: Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med319:964-971, 1988
103.
Girgis NI, Farid Z., Mikhail IA, et al: Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J8:848-851, 1989
104.
Canadian Pediatric Society, Infectious Diseases and Immunization Committee: Dexamethasone therapy for bacterial meningitis: A time for caution. Can Med Assoc J142:307-308,1990
105.
Kaplan SL: Dexamethasone for children with bacterial meningitis. Am J Dis Child143:290-292, 1989
106.
Havens PL, Wendelberger KJ, Hoffman GM, et al: Corticosteroids as adjunctive therapy in bacterial meningitis. A meta-analysis of clinical trials. Am J Dis Child143:1051-1055,1989
107.
Welsby PD, Golledge CL: Meningococcal meningitis. A diagnosis not to be missed. Br Med J300:1150-1151, 1990
108.
Jones DM: Control of meningococcal disease. Br Med J298:542-543, 1989
109.
Henry K., Crossley K.: Meningitis. Principles of diagnosis, advances in treatment. Postgrad Med80:59-71, 1986
110.
Centers for Disease Control: Update: Prevention of Haemophilus influenzae type b disease. MMWR37:13-16, 1988
111.
Centers for Disease Control: Food and Drug Administration approval of use of Haemophilus b conjugate vaccine for infants. MMWR39(39):1990
112.
American Academy of Pediatrics: AAP formulates provisional. recommendations for use of HIB vaccine in younger infants. AAP News Release, October 8,1990
113.
Black SB, Shinefield HR, Hiatt RA, et al: Efficacy of HbOC conjugate Haemophilus influenzae type b vaccine in a study population of 48,000 infants, in Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1990 (abstr)
114.
Eskola J., Peltola H., Takala A., et al: Protective efficacy of the Haemophilus inffuenzae type b conjugate vaccine HbOC in Finnish infants, in Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1990 (abstr)
115.
Decker MD, Edwards KM, Bradley R., et al: Four conjugate Haemophilus b vaccines in infants: A comparative trial, in Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1990 (abstr)
116.
Dickenson GM, Bisno AL: Infections associated with indwelling devices: Infections related to extravascular devices. Antimicrob Agents Chemother33:602-607,1989
117.
Aucoin PJ, Kotilainen HR, Gantz NM, et al: Intracranial pressure monitors: Epidemiologic study of risk factors and infections. Am J Med80:396-476, 1986
118.
Mayhill CG , Archer NH, Lamb VA, et al: Ventriculostomy-related infections: A prospective epidemiologic study. N Engl J Med310:553-559, 1984
119.
Gardner P. , Leipzig T., Phillips P.: Infections of central nervous system shunts . Med Clin North Am69:297-314,1985
120.
Forward KR , Fewer HD, Stiver HG: Cerebrospinal fluid shunt infections: A review of 35 infections in 32 patients. J Neurosurg59:389-394, 1983
121.
Schoenbaum SC, Gardner P., Shillito J.: Infections of cerebrospinal fluid shunts: Epidemiology, clinical menifestations and therapy. J Infect Dis131:543-552, 1975
122.
Younger JJ , Christensen GD, Bartley DL, et al: Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: Importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis156:548-554, 1987
123.
Diaz-Mitoma F., Harding Gkm, Hoban DJ, et al: Clinical significance of a test for slime production in ventriculoperiloneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis156:555-560, 1987
124.
Saez-Liorens XJ, Umana MA, Odio CM, et al: Brain abscess in infants and children . Pediatr Infect Dis J8:449-458, 1989
125.
Donald FE: Treatment of brain abscess. J Antimicrob Chemother25:310-312, 1990
126.
Renier D., Flandin C., Hirsch E., et al: Brain abscesses in neonates. A study of 30 cases. J Neurosurg69:877-882,1988
Ingham HR, Kalbog RM, Tharagonnet D., et al: Abscesses of the frontal lobe of the brain secondary to covert dental sepsis. Lancet2:497-499, 1978
129.
Harrison Mjg : The clinical presentation of intracranial abscesses . Q J Med204:461-468, 1982
130.
Alderson D. , Strong AJ, Ingham GR, et al: Fifteen-year review of the mortality of brain abscess. Neurosurgery8:1-6, 1981
131.
Heineman HS , Brande AI: Anaerobic infection of the brain. Observations on eighteen consecutive cases of brain abscess. Am J Med35:682-697,1963
132.
Rotheram EB Jr, Kessler LA: Use of computerized tomography in nonsurgical management of brain abscess. Arch Neurol36:25-26, 1979
133.
deLouvois J., Gortvai P., Hurley R.: Bacteriology of abscesses of the central nervous system: A muhicenirc prospective study. Br Med J2:981-984,1977
134.
Schliamser SE, Backman K., Norrby SR: Intracranial abscesses in adults: An analysis of 54 consecutive cases. Scand J Infect Dis20:1-9, 1988
135.
Britt RH, Enzmann DR, Yeager AS: Neuropathological and computerized tomographic findings in experimental brain abscess. J Neurosurg55:590-603,1981
136.
Samson DS, Clark K.: A current review of brain abscess. Am J Med54:201-210, 1973
137.
Boom WH, Tuazon CU: Successful treatment of multiple brain abscesses with antibiotics alone. Rev Infect Dis7:189-199,1985
138.
Whitley RJ, Nahmias AJ, Visintine AM, et al: The natural history of herpes simplex virus infection of mother and newborn. Pediatrics66:489-494, 1980
139.
Whitley RJ , Nahmias AJ, Soong SJ, et al: Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics66:495-501, 1980
140.
Nahmias AJ, Keyserling HL, Kennick GM: Herpes simplex, in Remington JS, Klein JO (eds): Infectious Disease of the Fetus and Newborn Infant (ed 2). Philadelphia, PA, Saunders, 1983 , pp 636-678
141.
Ho DD, Hirsch MS: Acute viral encephalitis. Med Clin North Am69:415-429,1985
142.
Ratzan KR: Viral meningitis. Med Clin North Am69:399-413, 1985
143.
Griffin DE, Johnson RT: Encephalitis, myelitis and neuritis, in Mandell GL, Douglas G, Bennett JE (eds): Principles and Practice of Infectious Diseases (ed 3). New York, NY , Churchill Livingstone, 1990, pp 762-769
144.
Centers for Disease Control: Encephalitis surveillance. CDC Annual Summary, May 1981
145.
Nahmias AJ , Whitley RJ, Visintine AN, et al: Herpes simplex virus encephalitis: Laboratory evaluations and their diagnostic significance. J Infect Dis145:829-836, 1982
146.
Hirsch MS: Herpes simplex virus, in Mandell GL, Douglas RE, Bennett JE (eds): Principles and Practice of Infectious Diseases (ed 3). New York, NY, Churchill Livingstone, 1990, pp 1144-1153
147.
Applebaum E., Krebs SL, Sunshine A.: Herpes zoster encephalitis. Am J Med32:25-31,1962
148.
Jemseck J. , Greenberg SB, Taber L., et al: Herpes zoster-associated encephalitis: Clinicopathologic report of 12 cases and review of the literature. Medicine62:81-97, 1983
149.
Ho M.: Cytomegalovirus, in Mandell GL, Douglas RG, Bennett JE (eds): Principles and Practice of Infectious Diseases (ed 3). New York, NY, Churchill Livingstone, 1990, pp 1159-1172
150.
Schooley RT, Dolin R.: Ebstein-Barr virus (infectious mononucleosis), in Mandell GL, Douglas RG, Bennett JE (eds): Principles and Practice of Infectious Diseases (ed 3). New York, NY, Churchill Livingstone, 1990, pp 1159-1172
151.
Levy RM, Bredesen DE, Rosenblum ML: Neurologic complications of HIV infection. Am Fam Physician41:517-536,1990
152.
Snider WD, Simpson DM, Nielson S., et al: Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol14:403-418, 1983
153.
Levy RM, Bredesen DE, Rosenblum ML: Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature. J Neurosurg62:475-49, 1985
154.
Shaw GM, Harper ME, Hahn BH, et al: HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science227:177-182, 1985
155.
Resnick L. , diMarzo-Veronese F., Schupbach J., et al: Intra-blood-brain-barrier synthesis of HTVL-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med313:1498-1504, 1985
156.
Ho DD, Rota TR, Schooley RT, et al: Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med313:1493-1497, 1985
157.
Levy JA, Shimabukuro J., Hollander H., et al: Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet2:586-588, 1985
158.
Koenig S., Gendelman HE, Orenstein JM, et al: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science233:1089-1093, 1986
159.
Sharer LR, Cho ES, Epstein LG: Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol16:760,1985
160.
Perry SW: Organic mental disorders by HIV: Update on early diagnosis and treatment. Am J Psychiatry147:696-710, 1990
161.
Dreyer EB, Kaiser PK, Offerman JT, et al: HIV-1 coat protein neurotoxicity prevented by calium channel antagonists. Science284:364-367,1990
162.
Shaunak S. , Albright RE, Klotman ME, et al: Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis161:1068-1072,1990
163.
Pizzo PA, Eddy J., Falloon J., et al: Effect of continuous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med319:889-896, 1988
164.
Brunetti A. , Berg G., BiChiro G., et al: Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3-azido-2,3-dideo.xythymidine (AZT, Zidovudine): A PET-FDG study. J Nucl Med30:581-590, 1989
165.
Gallis HA, Shipp KW, Nabors KL: Unit 3—Care of the patient with HIV infection, in Health Sciences Consortium (ed): Caring for Patients With HIV Infection. Research Triangle Park, NC , Glaxo Inc, 1989, pp 101-142
166.
Leport C.: Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med84:94-100,1988
167.
Levy RM, Janssen RS, Bush TJ, et al: Neuroepidemiology of acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr1:31-40,1988
Armstrong D., Gold Jwm, Dryjanski J., et al: Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med103:738-743, 1985
170.
Larsen RA: Azoles and AIDS. J Infect Dis162:727-730, 1990
171.
Perfect JR, Durack DT: Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits . J Antimicrob Chemother16:81-86,1985
172.
Perfect JR, Savani DV, Durack DT: Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob Agents Chemother29:579-583, 1986
173.
Arndt Cas, Walsh TJ, McCully CL, et al: Fluconazole penetration into cerebrospinal fluid: Implications for treating fungal infections of the central nervous system. J Infect Dis157:178-180, 1988
174.
Tucker RM, Williams PL, Arathoon EG, et al: Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother32:369-373, 1988
175.
Rinaldi MG, Robinson PA, Graybill JR, et al: Fluconazole (FLU) concentrations in patients undergoing antifungal therapy, in Program and Abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 1988 (abstr 121)
176.
Dismukes W., Cloud G., Tompson S., et al: Fluconazole versus amphotericin B therapy of acute cryptococcal meningitis, in Program and Abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy ( Houston). Washington, DC, American Society for Microbiology, 1989 (abstr 282)
177.
Byrne WR, Wajszczuk CP: Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): Successful treatment with fluconazole after failure of amphotericin B. Ann Intern Med108:384-385,1988
178.
Larsen RA, Leal Mab, Chan LS: Fluconazole with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med113:183-187, 1990
179.
Division of Acquired Immunodeficiency Syndrome. National Institute of Allergy and Infectius Diseases. National Institutes of Health: A note to physicians. Important information on results of a controlled clinical trial of fluconazole vs. amphotericin B for suppression of cryptococcal meningitis. May 1, 1990
180.
Gallis HA, Drew RH, PickardITVW: Amphotericin B: 30 years of clinical experience. Rev Infect Dis12:308-329, 1990
181.
Polsky B., Depman MR, Gold Jwm, et al: Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. JAMA81:24-28, 1986
182.
Katz D., Berger JR: Neurosyphilis in AIDS. Arch Neurol46:895-901, 1989
183.
Verghese A. , Gallemore G.: Kernig's and Brudzinski's signs revisited . Rev Infect Dis9:1187-1192, 1987